Cargando…

Decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722354/
https://www.ncbi.nlm.nih.gov/pubmed/36479336
http://dx.doi.org/10.18773/austprescr.2022.071
_version_ 1784843955427344384
collection PubMed
description
format Online
Article
Text
id pubmed-9722354
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-97223542022-12-06 Decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes Aust Prescr New Drugs NPS MedicineWise 2022-10-12 2022-12 /pmc/articles/PMC9722354/ /pubmed/36479336 http://dx.doi.org/10.18773/austprescr.2022.071 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes
title Decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes
title_full Decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes
title_fullStr Decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes
title_full_unstemmed Decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes
title_short Decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes
title_sort decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722354/
https://www.ncbi.nlm.nih.gov/pubmed/36479336
http://dx.doi.org/10.18773/austprescr.2022.071